Iwaki M, Makinoda S, Negishi H, Hanatani K, Tanaka T, Fujimoto S
Department of Obstetrics and Gynecology, Hokkaido University School of Medicine.
Jpn J Antibiot. 1991 Jun;44(6):659-61.
Clinical efficacies of flomoxef (FMOX), which is a newly developed oxacephem antibiotic, were evaluated in 14 cases of obstetric and gynecologic infections during the perinatal period. The results were excellent in 6 cases (42.9%) and good in 8 cases (57.1%). No side effects nor abnormal clinical laboratory test results were observed in mothers or neonates. Thus, FMOX appears to be a useful antibiotic for perinatal infections.
对新开发的氧头孢烯类抗生素氟氧头孢（FMOX）在14例围产期妇产科感染病例中的临床疗效进行了评估。结果为6例（42.9%）疗效极佳，8例（57.1%）疗效良好。未观察到母亲或新生儿出现副作用或临床实验室检查结果异常。因此，氟氧头孢似乎是一种用于围产期感染的有效抗生素。
